| Industry Range | | Price / Earnings | N/A | |
| Book Value | 7.26 | |
| Earnings Per Share | -$2.06 | |
| Price To Sales Ratio | 49.68 | |
| Price To Book Ratio | 1.66 | |
| Price To Tangible Book Ratio | 1.80 | |
| Price/Cash Flow Ratio | N/A | |
| Price/Free Cash Flow Ratio | N/A | |
| Industry Range | | Market Capitalization | 473.2M | |
| Float (MRQ) | 70.72% | |
| Shares Outstanding (MRQ) | 33.9M | |
| Short Interest as a % of Float (MRQ) | 6.66% | |
| Shares Held By Institutions (MRQ) | 20.5M | |
| Industry Range | | Sales | $9.7M | |
| Gross Margin | N/A | |
| Net Profit Margin | -637.19% | |
| EBIT Margin | -631.38% | |
| EBITDA Margin | -589.58% | |
| Operating Margins | -631.38% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 17.31 | |
| Quick Ratio (MRQ) | 17.31 | |
| Total Debt/Equity Ratio (MRQ) | 6.91 | |
| Debt/Common Equity Ratio (MRQ) | 6.91 | |
| Industry Range | | Return on Equity | -25.18% | |
| Return on Assets | -26.76% | |
| Asset Turnover | 0.04 | |
| Receivables Turnover | N/A | |
| Inventory Turnover | N/A | |
| Industry Range | | EPS Growth Annual | -63.56% | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | 0.00% | |
| Current Payout Ratio | N/A | |
*ACET does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.22%